INTELLECTUAL PROPERTY:
Harbinger Medical has broad intellectual property protection of its technologies. Harbinger Medical currently has twenty issued and pending patents in the United States and throughout the world. Harbinger is committed to protecting its proprietary position by a combination of both offensive and defensive patent strategies.
The Harbinger technology is protected by the following issued patents and additional pending US and International
patents.
U.S. PATENTS
5,117,834 Method and apparatus for non-invasively determining
a patient's susceptibility to ventricular arrhythmias
5,351,687 Method and apparatus for non-invasively determining
a patient's susceptibility to ventricular arrhythmias
5,555,888 Method for automatic, adaptive, active facilitation to access myocardial electrical instability
5,694,943 Method and apparatus for automatic, adaptive, active facilitation to assess myocardial electrical instability
5,951,484 Method of noninvasively determining a patient's susceptibility to arrhythmia
6,129,678 System of noninvasively determining a patient's susceptibility to arrhythmia
6,445,947 Noninvasive diagnosis of a patient's cardiac condition
6,512,945 Method of noninvasively determining a patient's susceptibility to arrhythmia
6,625,483 Method of noninvasively determining a patient's susceptibility to arrhythmia
6,850,795 Method of noninvasively determining a patient's susceptibility to arrhythmia
7,016,731 Sensing artifact reduction for cardiac diagnostic system
7,171,265 Apparatus and method for detecting lead adequacy and quality
INTERNATIONAL PATENTS
EP 1 384 434 B1 DE Sensing artifact reduction for cardiac diagnostic system
EP 1 384 434 B1 B Sensing artifact reduction for cardiac diagnostic system
